Purpose
The study was purposed to investigate the effect of COVID-19 disease on fatigue, sleep quality, physical activity, quality of life, and psychological status in people with MS.
Methods
A total of 104 people with MS, including 46 of them with COVID-19 disease history, were enrolled in the study. All patients were evaluated with the Expanded Disability Status Scale (EDSS), Fatigue Severity Scale (FSS), Pittsburgh Sleep Quality Index (PSQI), International Physical Activity Questionnaire Short Form (IPAQ-SF), the EuroQoL Instrument (EQ-5D-3L), the Fear of COVID-19 Scale (FCV-19S) and the Coronavirus Anxiety Scale (CAS).
Results
People with MS in the COVID-19 positive group had a significantly lower IPAQ-Total score (
p
= 0.014). Besides, the FCV-19S scores of COVID-19 positive patients were significantly higher (
p
= 0.006). EQ-5D-3L Index and EQ-5D-3L VAS scores were higher in the group with COVID-19 (p
1
= 0.021, p
2
= 0.014, respectively). FCV-19S had a moderate correlation with EDSS (
r
= -0.362). IPAQ-Total was moderately associated with MS duration, EDSS and FSS (r
1
= -0.471, r
2
= -0.389, r
3
= -0.388, respectively). The EQ-5D-3L Index was moderately correlated with FSS (r
1
= -0.404). There was a weakly significant relationship between EQ-5D-3L Index and BMI, MS duration, PSQI and CAS (r
1
= -0.471, r
2
=-0.389, r
3
= -0.388, r
4
= -0.326, respectively). On the other hand, EQ-5D-3L was moderately associated with VAS and EDSS and PSQI (r
1
= -0.393, r
2
= -0.357, respectively).
Conclusion
COVID-19 negatively affected the people with MS's physical activity and coronavirus related fear parameters. However, the causality of this influence should be investigated in detail.